Comparative evaluation of cleavase fragment length polymorphism with PCR-SSCP and PCR-RFLP to detect antimicrobial agent resistance in Mycobacterium tuberculosis

被引:17
作者
Sreevatsan, S
Bookout, JB
Ringpis, FM
Mogazeh, SL
Kreiswirth, BN
Pottathil, RR
Raj, R
机构
[1] ClinCyte, Ctr Innovat Technol, San Diego, CA 92121 USA
[2] Publ Hlth Res Inst, Mycobacteriol Lab, New York, NY USA
[3] AccuDx, San Diego, CA USA
来源
MOLECULAR DIAGNOSIS | 1998年 / 3卷 / 02期
关键词
rpoB; katG; rifampicin; isoniazid;
D O I
10.1016/S1084-8592(98)80056-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Several molecular methods potentially useful in the detection of Mycobacterium tuberculosis mutations, specifically in rpoB and katG, were compared. Methods and Results: DNA from 24 M. tuberculosis clinical isolates, with mutations associated with resistance to rifampin and/or isoniazid, was analyzed. A 128 bp amplicon, spanning the 81 bp rpoB region containing most mutations leading to rifampin resistance, was analyzed by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and a recently introduced mutation scanning method, cleavase fragment length polymorphism (CFLP) analysis. Also, a 350 bp amplicon encompassing that region was analyzed by the CFLP method. CFLP analysis of the 350 bp amplicon (23 isolates) identified 14 of 17 mutants; however? CFLP analysis of the 128 bp amplicon accurately identified all mutants as did PCR-SSCP with interpretative difficulty for two codon 513 mutations. CFLP and PCR-restriction fragment length polymorphism (RFLP) analyses of a 623 bp amplicon encompassing katG codons 315 and 463 showed that the CFLP method identified single and dinucleotide codon 315 substitutions with or without codon 463 (CGG-->CTG) changes, whereas PCR-RFLP (MspI) missed one codon 315 polymorphism (AGC-->ACA) in three isolates. Conclusion: Both PCR-SSCP and CFLP analyses were sensitive in identifying all mutations on short sequences in the rpoB mutants. CFLP appears to be more efficient than SSCP and RFLP for the detection of mutations in large amplicons.
引用
收藏
页码:81 / 91
页数:11
相关论文
共 25 条
[1]   Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family [J].
Bifani, PJ ;
Plikaytis, BB ;
Kapur, V ;
Stockbauer, K ;
Pan, X ;
Lutfey, ML ;
Moghazeh, SL ;
Eisner, W ;
Daniel, TM ;
Kaplan, MH ;
Crawford, JT ;
Musser, JM ;
Kreiswirth, BN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (06) :452-457
[2]  
BLOCH AB, 1994, JAMA-J AM MED ASSOC, V271, P655
[3]   Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage [J].
Brow, MAD ;
Oldenburg, MC ;
Lyamichev, V ;
Heisler, LM ;
Lyamicheva, N ;
Hall, JG ;
Eagan, NJ ;
Olive, DM ;
Smith, LM ;
Fors, L ;
Dahlberg, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3129-3137
[4]   RAPID IDENTIFICATION OF A POINT MUTATION OF THE MYCOBACTERIUM-TUBERCULOSIS CATALASE-PEROXIDASE (KATG) GENE ASSOCIATED WITH ISONIAZID RESISTANCE [J].
COCKERILL, FR ;
UHL, JR ;
TEMESGEN, Z ;
ZHANG, Y ;
STOCKMAN, L ;
ROBERTS, GD ;
WILLIAMS, DL ;
KLINE, BC .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :240-245
[5]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[6]   Rifamycin resistance in mycobacteria [J].
Cole, ST .
RESEARCH IN MICROBIOLOGY, 1996, 147 (1-2) :48-52
[7]  
Cole Stewart T., 1994, Trends in Microbiology, V2, P411, DOI 10.1016/0966-842X(94)90621-1
[8]   Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from new York City [J].
Cooksey, RC ;
Morlock, GP ;
Glickman, S ;
Crawford, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1281-1283
[9]  
KAPUR V, 1995, ARCH PATHOL LAB MED, V119, P131
[10]   Determination of hepatitis C virus genotypes in the United States by Cleavase Fragment Length Polymorphism analysis [J].
Marshall, DJ ;
Heisler, LH ;
Lyamichev, V ;
Murvine, C ;
Olive, DM ;
Ehrlich, GD ;
Neri, BP ;
deArruda, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3156-3162